Low PSA (prostate specific antigen) score can predict cancer return after radiation:
This article was originally published in Clinica
Executive Summary
Individuals with a low prostate specific antigen (PSA) score are less prone to the disease, but new research has suggested that a low PSA score after radiation therapy in prostate cancer patients may predict the likelihood of whether cancer will return in the prostate or elsewhere. The study was published in the International Journal of Radiation Oncology*Biology*Physics (March 15). "These findings may help us to identify high-risk patients early. This will allow doctors to consider other adjuvant or salvage therapies to hopefully increase their chances for survival," commented Michael Ray, lead author of the study.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.